NCT06854042View on ClinicalTrials.gov

A Study of Oral E1018 in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

December 23, 2025

Study Completion Date

December 23, 2025

Conditions
MalariaHealthy Participants
Interventions
DRUG

E1018

Specified dose on specified days.

DRUG

Placebo

E1018 matching placebo on specified days.

Trial Locations (1)

78744

RECRUITING

PPD Development, LP, Austin

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY